ウィスコンシンにおける胃癌の臨床試験
ウィスコンシン内の拠点で、胃癌に関する18件の研究が参加者を募集しています。
ウィスコンシン内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- 他29件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- 他50件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- University of Wisconsin Carbone Cancer Center, Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07700979Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Madison
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- University of Wisconsin - Carbone Cancer Center, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
- Medical College of Wisconsin, Milwaukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07217704Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Milwaukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- The Board of Regents of the University of Wisconsin, Madison
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Wisconsin, Madison
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Combination of TATE and PD-1 Inhibitor in Liver Cancer
- Medical College of Wisconsin, Milwaukee
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/04/16更新 · NCT03259867Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- UW Carbone Cancer Center, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/05更新 · NCT04900818SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of Wisconsin, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2025/06/27更新 · NCT03175224ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。